These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Cardiac arrest after fast intravenous infusion of phenytoin mistaken for fosphenytoin. DeToledo JC; Lowe MR; Rabinstein A; Villaviza N Epilepsia; 2001 Feb; 42(2):288. PubMed ID: 11240605 [No Abstract] [Full Text] [Related]
11. Phenytoin and fosphenytoin: a model of cost and clinical outcomes. Armstrong EP; Sauer KA; Downey MJ Pharmacotherapy; 1999 Jul; 19(7):844-53. PubMed ID: 10417033 [TBL] [Abstract][Full Text] [Related]
12. Fosphenytoin: a novel phenytoin prodrug. Boucher BA Pharmacotherapy; 1996; 16(5):777-91. PubMed ID: 8888074 [TBL] [Abstract][Full Text] [Related]
13. Cost-minimization analysis of phenytoin and fosphenytoin in the emergency department. Touchette DR; Rhoney DH Pharmacotherapy; 2000 Aug; 20(8):908-16. PubMed ID: 10939551 [TBL] [Abstract][Full Text] [Related]
14. Fosphenytoin and phenytoin in patients with status epilepticus: improved tolerability versus increased costs. DeToledo JC; Ramsay RE Drug Saf; 2000 Jun; 22(6):459-66. PubMed ID: 10877039 [TBL] [Abstract][Full Text] [Related]
15. Fosphenytoin: worth the cost? Miller MH Ann Emerg Med; 1997 Jun; 29(6):823. PubMed ID: 9174533 [No Abstract] [Full Text] [Related]
16. Cost of fosphenytoin. Marble EL Ann Emerg Med; 1998 Jan; 31(1):138-9. PubMed ID: 9437362 [No Abstract] [Full Text] [Related]
17. Pharmacoeconomic considerations in treatment options for acute seizures. Graves N J Child Neurol; 1998 Oct; 13 Suppl 1():S27-9; discussion S30-2. PubMed ID: 9796750 [TBL] [Abstract][Full Text] [Related]
18. A pharmacoeconomic evaluation of intravenous fosphenytoin (Cerebyx) versus intravenous phenytoin (Dilantin) in hospital emergency departments. Marchetti A; Magar R; Fischer J; Sloan E; Fischer P Clin Ther; 1996; 18(5):953-66. PubMed ID: 8930434 [TBL] [Abstract][Full Text] [Related]